---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-043755"
form_type: "8-K"
ticker: "RMTG"
cik: "0001760026"
company_name: "Regenerative Medical Technology Group Inc."
filed_at: "2021-08-19T23:59:59+00:00"
generated_at: "2026-06-29T08:58:43.165329+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Meso Numismatics closes Global Stem Cells Group acquisition; renegotiates $10.5M financing

## Summary
- Acquired all GCSC shares for 1M Series AA Preferred, 8,974 Series DD Preferred, and $225,000 cash.
- Issuance of 1M Series AA Preferred to Benito Novas caused change of control; Novas and CEO jointly control 67% vote.
- Renegotiated June 2021 $10.5M financing: warrant maturity extended to 7 years, locked up for first 2 years.
- $8.2M earmarked for Lans Holdings escrow per prior agreement.
- Entered consulting agreement with ETC (owned by CEO) for 896 Series DD Preferred shares.

## SEC filing metadata
- accession: 0001213900-21-043755
- form_type: 8-K
- ticker: RMTG
- cik: 0001760026
- company_name: Regenerative Medical Technology Group Inc.
- filed_at: 2021-08-19T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 5.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760026/000121390021043755/0001213900-21-043755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760026/000121390021043755/ea146148-8k_mesonumis.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-043755
- JSON: https://secwatch.observer/filing/0001213900-21-043755.json
- Plain text: https://secwatch.observer/filing/0001213900-21-043755.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.